Lucy Therapeutics develops targeted therapies for mitochondrial diseases and neurodegenerative disorders by focusing on mitochondrial protein modulation. The company aims to improve cellular energy production and reduce neurodegeneration, addressing critical health challenges associated with these conditions.
Funding
$42.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Mitochondrial diseases and neurodegenerative disorders often stem from impaired cellular energy production and mitochondrial dysfunction. Current treatments provide limited symptomatic relief but do not address the underlying mitochondrial protein imbalances that contribute to disease progression. This leaves a significant unmet need for therapies that can directly modulate mitochondrial function and prevent neurodegeneration.
Solution
Lucy Therapeutics develops targeted therapies designed to modulate mitochondrial proteins and improve cellular energy production in patients with mitochondrial diseases and neurodegenerative disorders. Their approach focuses on identifying and correcting imbalances in mitochondrial protein expression to restore optimal mitochondrial function. By targeting the root causes of these diseases at the mitochondrial level, Lucy Therapeutics aims to develop disease-modifying treatments that can slow or halt disease progression and improve patient outcomes. The company's research seeks to enhance mitochondrial health, reduce neurodegeneration, and ultimately provide more effective therapeutic options for these challenging conditions.
Target Audience
The primary target audience includes patients suffering from mitochondrial diseases and neurodegenerative disorders, as well as healthcare providers specializing in these conditions.
Features
- Focus on mitochondrial protein modulation to address the underlying causes of disease
- Development of targeted therapies for mitochondrial diseases and neurodegenerative disorders
- Aims to improve cellular energy production and reduce neurodegeneration